At Pure Dermatology, we advance skincare science by partnering with top companies to explore innovative treatments, including topical medications, lasers, dermal fillers, and neuromodulators.
Our clinical research program provides a comfortable, professional space for participants, offering exclusive access to the latest advancements in skincare. Open to both new and current patients, our studies are led by Dr. Kate Holcomb and Dr. Mara Haseltine, Board-Certified Dermatologists, ensuring the highest standards of safety and efficacy.
Interested in participating in a clinical trial? Complete the form, and a member of our research team will reach out.
Study sponsors, please contact us at 504-226-7873 or email clinicalstudy@puredermnola.com.
Pure Dermatology has 3 aesthetic injectable studies that we are recruiting for. Patients will receive FREE filler and earn about $1000 for participating fully. Results vary because every patient is unique but below are examples of the areas being treated in the studies.
A Study to Assess Safety and Effectiveness of Injections of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Change of Mid-Face Volume.
A Prospective, Open-Label Study to Evaluate Subject Satisfaction With Overall Facial Appearance After Treatment With JUVÉDERM® Products in Medical Weight Loss (MWL) Subjects
A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants. Study enrollment here.
Interested in participating in an upcoming study? Fill out the form at the bottom of the page to see if you qualify for an upcoming study.
Psychometric Validation of the Allergan Face and Neck Core Concept Scales.
A study to collect and analyze data about Psoriasis patients being treated in a clinical setting to study the safety and effectiveness of FDA-approved systemic therapies.
A study using non-invasive methods to investigate biomarkers in atopic dermatitis (AD) patients.
A long-term registry study to investigate outcomes in patients with psoriasis.
A study to assess the risk of trophic acne scar formation with the use of Trifarotene Cream.
A study evaluating the long-term treatment of moderate to severe glabellar lines and lateral canthal lines.
A phase 4 study looking at the safety and efficacy of trifarotene (Aklief) cream in preventing atrophic acne scars in patients with Fitzpatrick skin types I-VI.